Key Considerations for Office to Life Science, Medical or Multifamily Conversions Webinar

Recorded On: 05/24/2022

You must log in to register
- Prices available after logging in
Continue

Office utilization has been in recent decline due to the COVID-19 pandemic, while other property types – including life science, medical office and multifamily – are in demand. More favorable market conditions for these property types are leading building owners and developers in many markets across the U.S. to consider converting existing office buildings to new uses. In this webinar, hear from both the author of a recent NAIOP Research Foundation report about the risks and opportunities associated with office building conversions, and architects with experience in these types of conversions who can provide an overview of the key considerations that go into converting an office building to a life science, medical office or multifamily use.

Speakers:
Emil Malizia, PhD, CRE, Research Professor, Department of City & Regional Planning, The University of North Carolina at Chapel Hill
Neal McFarlane, AIA NCARB IIDA, Owner, McFarlane Architects
Steven Paynter, OAA, ARB, Principal, Gensler

Thanks to our sponsor:

Emil Malizia, PhD, CRE

Research Professor, Department of City & Regional Planning

The University of North Carolina at Chapel Hill

Emil Malizia, PhD, CRE, is Research Professor of City and Regional Planning at the University of North Carolina-Chapel Hill and President of Malizia & Associates, LLC.
His expertise spans the related areas of regional economic development, real estate development and urban redevelopment.
His recent activities include helping NCCU’s Business School launch a new real estate program and counseling local development firms on workforce housing.
He is a member of the American Real Estate Society, American Planning Association, Counselors of Real Estate, International Economic Development Council, National Association of Realtors and Urban Land Institute.

Neal McFarlane, AIA NCARB IIDA

Owner

McFarlane Architects

Neal McFarlane is the sole owner of McFarlane Architects, a mid-sized architectural, planning, and interior design firm that specializes in the design of life science and advanced technology facilities, based in San Diego, California. The firm practices in multiple geographic markets including Los Angeles, San Francisco, Phoenix, and Salt Lake City.
Mr. McFarlane entered the architectural profession in 1985, working for small, mid-sized, and national A/E firms until he began McFarlane Architects in 2003.
McFarlane is responsible for the success, design, and management of each project. He personally leads the design and programming of each project and supervises each project manager to ensure the client’s goals are achieved.
He is licensed in California, Arizona, Utah, and Texas, and has designed more than 12,000,000 square feet of life science facilities including some highly specialized, first-of-their-kind facilities.

Steven Paynter, OAA, ARB

Principal

Gensler

Embodying the philosophy that diversity fosters innovation, Steven is widely recognized as an industry leader and an invaluable resource for market expertise to developers, landlords, and tenants alike. His ability to combine technical execution with elegant design and his commitment to each project makes him sought-after by clients across all industries.
Steven is frequently called on to provide thought leadership and regularly speaks on topics such as unlocking the value of Class B & C buildings by converting them to residential, shaping the future of cities, the urbanization of suburbia, and design of post-pandemic office buildings.
Engaged in original research, he has led the development of a tool for rapid assessment of existing office building stock for ESG performance.
Steven was nominated by Business Insider as one of their Top 100 People Transforming Business in 2022, and his work and leadership have been featured in the Globe and Mail, Toronto Star, Calgary Herald, CBC, BBC, South China Morning Post, RTE and Architectural Record.